APA (7th ed.) Citation

T, M., M, N., M, S., T, N., & N, F. (2026). Serum Prolactin Levels as an Intraindividual Biomarker for Guiding Osmotic-Release Oral System-Methylphenidate Therapy: Three Case Reports. American journal of therapeutics. https://doi.org/10.1097/MJT.0000000000002125

Chicago Style (17th ed.) Citation

T, Murata, Nagaoka M, Sakamoto M, Nagamine T, and Fujise N. "Serum Prolactin Levels as an Intraindividual Biomarker for Guiding Osmotic-Release Oral System-Methylphenidate Therapy: Three Case Reports." American Journal of Therapeutics 2026. https://doi.org/10.1097/MJT.0000000000002125.

MLA (9th ed.) Citation

T, Murata, et al. "Serum Prolactin Levels as an Intraindividual Biomarker for Guiding Osmotic-Release Oral System-Methylphenidate Therapy: Three Case Reports." American Journal of Therapeutics, 2026, https://doi.org/10.1097/MJT.0000000000002125.